000 | 01177 a2200337 4500 | ||
---|---|---|---|
005 | 20250514212759.0 | ||
264 | 0 | _c20050413 | |
008 | 200504s 0 0 eng d | ||
022 | _a0007-0963 | ||
024 | 7 |
_a10.1111/j.1365-2133.2004.06277.x _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aSimeone, P | |
245 | 0 | 0 |
_aEndothelin-1 could be one of the targets of psoriasis therapy. _h[electronic resource] |
260 |
_bThe British journal of dermatology _cDec 2004 |
||
300 |
_a1273-5 p. _bdigital |
||
500 | _aPublication Type: Letter; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 | _aAtrasentan |
650 | 0 | 4 | _aCells, Cultured |
650 | 0 | 4 |
_aDermatologic Agents _xpharmacology |
650 | 0 | 4 |
_aEndothelin-1 _xantagonists & inhibitors |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aKeratinocytes _xdrug effects |
650 | 0 | 4 |
_aPsoriasis _xdrug therapy |
650 | 0 | 4 |
_aPyrrolidines _xpharmacology |
700 | 1 | _aTeson, M | |
700 | 1 | _aLatini, A | |
700 | 1 | _aCarducci, M | |
700 | 1 | _aVenuti, A | |
773 | 0 |
_tThe British journal of dermatology _gvol. 151 _gno. 6 _gp. 1273-5 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1111/j.1365-2133.2004.06277.x _zAvailable from publisher's website |
999 |
_c15288565 _d15288565 |